Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Mufti

Showing results (21-30 of 202) with videos related to

Pageof 21
Sort By:
British Journal of Cancer|September 1, 1987
Human cancer DNA fingerprint analysisD M Layton, G J Mufti
BMJ (Clinical Research Ed.)|December 8, 1990
Hypoalbuminaemia after prolonged treatment with recombinant granulocyte macrophage colony stimulating factorR S Kaczmarski, G J Mufti
Leukemia & Lymphoma|June 28, 2001
Excessive apoptosis in low risk myelodysplastic syndromes (MDS)J E Parker, G J Mufti
British Journal of Haematology|June 1, 1993
Management of myelodysplastic syndromesW J Hirst, G J Mufti
Blood|January 1, 1992
Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsiesM H Mangi, G J Mufti
British Journal of Haematology|June 3, 1998
Ineffective haemopoiesis and apoptosis in myelodysplastic syndromesJ E Parker, G J Mufti
Postgraduate Medical Journal|March 1, 1990
Palmar-plantar erythema associated with combination chemotherapyA Pagliuca, R Kaczmarski, G J Mufti
International Journal of Hematology|April 17, 2016
Clinical significance of acquired somatic mutations in aplastic anaemiaJ C W Marsh, G J Mufti
International Journal of Hematology|April 1, 1993
Myelodysplastic syndromes: from morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasiaY Yoshida, J Stephenson, G J Mufti
Annals of Hematology|August 20, 2002
Intraperitoneal rituximab: an effective measure to control recurrent abdominal ascites due to non-Hodgkin's lymphomaT Ng, A Pagliuca, G J Mufti
Pageof 21

Showing results (21-30 of 202) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|September 1, 1987
Human cancer DNA fingerprint analysisD M Layton, G J Mufti
BMJ (Clinical Research Ed.)|December 8, 1990
Hypoalbuminaemia after prolonged treatment with recombinant granulocyte macrophage colony stimulating factorR S Kaczmarski, G J Mufti
Leukemia & Lymphoma|June 28, 2001
Excessive apoptosis in low risk myelodysplastic syndromes (MDS)J E Parker, G J Mufti
British Journal of Haematology|June 1, 1993
Management of myelodysplastic syndromesW J Hirst, G J Mufti
Blood|January 1, 1992
Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsiesM H Mangi, G J Mufti
British Journal of Haematology|June 3, 1998
Ineffective haemopoiesis and apoptosis in myelodysplastic syndromesJ E Parker, G J Mufti
Postgraduate Medical Journal|March 1, 1990
Palmar-plantar erythema associated with combination chemotherapyA Pagliuca, R Kaczmarski, G J Mufti
International Journal of Hematology|April 17, 2016
Clinical significance of acquired somatic mutations in aplastic anaemiaJ C W Marsh, G J Mufti
International Journal of Hematology|April 1, 1993
Myelodysplastic syndromes: from morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasiaY Yoshida, J Stephenson, G J Mufti
Annals of Hematology|August 20, 2002
Intraperitoneal rituximab: an effective measure to control recurrent abdominal ascites due to non-Hodgkin's lymphomaT Ng, A Pagliuca, G J Mufti
Pageof 21